PUBLIC COMPANY
saveARCE Therapeutics Inc
founded 2020 · 30 employees · Taipei, TWupdated 1mo ago
ARCE Therapeutics is a Taiwan-based discovery to clinical-stage biotech company, founded in 2020 as a subsidiary of Compal, developing proprietary gene-modified cellular immunotherapies via its DashCAR, MaxCAR, and OneCAR platforms. Its lead candidate ARD-103 is a CLL-1/CLEC12A-targeted CAR-T therapy in Phase 1/2 trials for relapsed or refractory acute myeloid leukemia.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
comments(0)
5-min edit window · permanent after that